Metacrine, Inc.
FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
Last updated:
Abstract:
Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
Status:
Application
Type:
Utility
Filling date:
22 Nov 2021
Issue date:
17 Mar 2022